Questions?arveonix@protonmail.com•Telegram @arveonix

Last updated:

ARVEONIX BPC-157 20mg research product box and vial
Tissue research · SKU BC20

BPC-157 20mg

$100.00 AUD
In stock
Free shipping Australia-wideOrders over $150

BPC-157 is a synthetic pentadecapeptide studied in preclinical gastrointestinal, tissue, vascular and inflammatory-signalling research.

ProductBPC-157 20mg
SKUBC20
CategoryTissue research
Listed price$100.00 AUD
AvailabilityIn stock
Confirm current availability when making an enquiry.

What is BPC-157?

BPC-157 is a synthetic pentadecapeptide that appears primarily in preclinical research literature. Investigators have studied it across gastrointestinal, vascular, tissue-response and inflammatory-signalling models.

The ARVEONIX 20mg listing is a higher-strength catalogue format of the same research peptide offered on the 10mg page. Strength does not change the identity of the molecule or convert preclinical findings into established human outcomes.

Research category

Tissue research

ARVEONIX format

BPC-157 20mg · SKU BC20

Primary research context

BPC-157 research context

Catalogue status

In stock · $100.00 AUD

BPC-157 research context.

Unlike peptides defined by a single well-characterised receptor target, BPC-157 is discussed across multiple proposed biological pathways. This makes study design and evidence quality particularly important.

Researchers should separate mechanistic hypotheses from replicated findings and distinguish animal or cell-model observations from clinical evidence.

Common research themes.

Gastrointestinal models

Study of gastrointestinal tissue and barrier-associated biology.

Vascular biology

Investigation of endothelial and vascular signalling.

Tissue response

Preclinical research involving repair-associated cellular processes.

Evidence quality

Careful distinction between mechanistic hypotheses and established findings.

Research considerations.

Research findings should always be interpreted within the experimental system in which they were produced. Cell, receptor, tissue, animal and human studies can answer different questions, and results from one model should not automatically be treated as established outcomes in another.

ARVEONIX product pages therefore focus on molecule identity, pathway biology and published research themes rather than presenting experimental observations as guaranteed effects. The information here is not a dosing, treatment or individual-use recommendation.

BPC-157 FAQs.

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide used in preclinical research.

How does the 20mg product differ from the 10mg product?

The molecule is the same; the catalogue listing differs in total stated strength.

What areas are studied?

Gastrointestinal, vascular, tissue and inflammatory-signalling models.

Is BPC-157 research predominantly preclinical?

Yes. Much of the commonly discussed literature is preclinical.

What is the SKU?

The 20mg ARVEONIX listing uses SKU BC20.

Is BPC-157 a thymosin peptide?

No. It is distinct from thymosin-beta-derived research peptides such as TB-500.

Does this page provide human-use recommendations?

No.